Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$33.57 - $48.66 $832,536 - $1.21 Million
24,800 Added 364.71%
31,600 $1.54 Million
Q4 2023

Feb 14, 2024

SELL
$25.42 - $37.19 $813,440 - $1.19 Million
-32,000 Reduced 82.47%
6,800 $236,000
Q3 2023

Nov 14, 2023

BUY
$27.3 - $34.99 $649,740 - $832,762
23,800 Added 158.67%
38,800 $1.09 Million
Q2 2023

Aug 14, 2023

SELL
$25.0 - $33.44 $382,500 - $511,631
-15,300 Reduced 50.5%
15,000 $489,000
Q1 2023

May 15, 2023

SELL
$18.18 - $25.07 $52,722 - $72,703
-2,900 Reduced 8.73%
30,300 $758,000
Q4 2022

Feb 14, 2023

BUY
$15.17 - $21.05 $288,230 - $399,950
19,000 Added 133.8%
33,200 $625,000
Q3 2022

Nov 14, 2022

SELL
$17.2 - $23.02 $220,160 - $294,656
-12,800 Reduced 47.41%
14,200 $289,000

Others Institutions Holding RDNT

About RadNet, Inc.


  • Ticker RDNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,310,000
  • Market Cap $3.4B
  • Description
  • RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modali...
More about RDNT
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.